ITMI921551A1 - Glutatione come agente chemioprotettivo - Google Patents

Glutatione come agente chemioprotettivo

Info

Publication number
ITMI921551A1
ITMI921551A1 IT001551A ITMI921551A ITMI921551A1 IT MI921551 A1 ITMI921551 A1 IT MI921551A1 IT 001551 A IT001551 A IT 001551A IT MI921551 A ITMI921551 A IT MI921551A IT MI921551 A1 ITMI921551 A1 IT MI921551A1
Authority
IT
Italy
Prior art keywords
pct
glutatione
chemoprotective agent
sec
date
Prior art date
Application number
IT001551A
Other languages
English (en)
Inventor
Ennio Cavalletti
Sergio Tognella
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/351,403 priority Critical patent/US5618823A/en
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Publication of ITMI921551A0 publication Critical patent/ITMI921551A0/it
Priority to ITMI921551A priority patent/IT1254990B/it
Priority to DE69309929T priority patent/DE69309929T2/de
Priority to AU43254/93A priority patent/AU673175B2/en
Priority to JP6501993A priority patent/JPH07507325A/ja
Priority to EP93912964A priority patent/EP0651647B1/en
Priority to PCT/EP1993/001494 priority patent/WO1994000141A1/en
Priority to AT93912964T priority patent/ATE151639T1/de
Priority to NZ253130A priority patent/NZ253130A/en
Priority to CA002138992A priority patent/CA2138992A1/en
Publication of ITMI921551A1 publication Critical patent/ITMI921551A1/it
Application granted granted Critical
Publication of IT1254990B publication Critical patent/IT1254990B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ITMI921551A 1992-06-24 1992-06-24 Glutatione come agente chemioprotettivo IT1254990B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US08/351,403 US5618823A (en) 1992-06-24 1992-06-14 Glutathione as chemoprotective agent
ITMI921551A IT1254990B (it) 1992-06-24 1992-06-24 Glutatione come agente chemioprotettivo
JP6501993A JPH07507325A (ja) 1992-06-24 1993-06-14 化学保護剤としてのグルタチオン
AU43254/93A AU673175B2 (en) 1992-06-24 1993-06-14 Glutathione as chemoprotective agent
DE69309929T DE69309929T2 (de) 1992-06-24 1993-06-14 Glutathion als chemoschützender wirkstoff
EP93912964A EP0651647B1 (en) 1992-06-24 1993-06-14 Glutathione as chemoprotective agent
PCT/EP1993/001494 WO1994000141A1 (en) 1992-06-24 1993-06-14 Glutathione as chemoprotective agent
AT93912964T ATE151639T1 (de) 1992-06-24 1993-06-14 Glutathion als chemoschützender wirkstoff
NZ253130A NZ253130A (en) 1992-06-24 1993-06-14 Pharmaceutical compositions of glutathione and an antitumour drug active on the mitotic spindle
CA002138992A CA2138992A1 (en) 1992-06-24 1993-06-14 Glutathione as chemoprotective agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921551A IT1254990B (it) 1992-06-24 1992-06-24 Glutatione come agente chemioprotettivo

Publications (3)

Publication Number Publication Date
ITMI921551A0 ITMI921551A0 (it) 1992-06-24
ITMI921551A1 true ITMI921551A1 (it) 1993-12-24
IT1254990B IT1254990B (it) 1995-10-11

Family

ID=11363571

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921551A IT1254990B (it) 1992-06-24 1992-06-24 Glutatione come agente chemioprotettivo

Country Status (10)

Country Link
US (1) US5618823A (it)
EP (1) EP0651647B1 (it)
JP (1) JPH07507325A (it)
AT (1) ATE151639T1 (it)
AU (1) AU673175B2 (it)
CA (1) CA2138992A1 (it)
DE (1) DE69309929T2 (it)
IT (1) IT1254990B (it)
NZ (1) NZ253130A (it)
WO (1) WO1994000141A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021444A1 (en) * 1995-12-14 1997-06-19 Mark Borisovich Balazovsky Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
JP5242877B2 (ja) * 2000-04-26 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティー チオールをベースとする化学保護剤の投与
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
AU2005263729B2 (en) * 2004-07-22 2011-01-06 Bey Pharma GmbH Use of compounds containing thiol groups as an efflux pump inhibitor
US8602961B2 (en) * 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
WO2023199241A1 (en) * 2022-04-12 2023-10-19 URIACH ITALY S.r.l. Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof
IT202200007232A1 (it) * 2022-04-12 2023-10-12 Uriach Italy S R L Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1176983B (it) * 1984-10-16 1987-08-26 Zambon Spa Dipeptidi ad attivita' farmacologica
IL84114A (en) * 1986-10-07 1994-01-25 Boehringer Mannheim Italia Anti-neoplastic pharmaceutical compositions containing HSG together with an anti-tumor drug
EP0486621A4 (en) * 1989-08-09 1993-03-31 The Children's Medical Center Corporation Nmda oxidizing agents for protecting neurons from injury

Also Published As

Publication number Publication date
AU4325493A (en) 1994-01-24
JPH07507325A (ja) 1995-08-10
EP0651647B1 (en) 1997-04-16
WO1994000141A1 (en) 1994-01-06
CA2138992A1 (en) 1994-01-06
ITMI921551A0 (it) 1992-06-24
DE69309929T2 (de) 1997-09-04
IT1254990B (it) 1995-10-11
US5618823A (en) 1997-04-08
DE69309929D1 (de) 1997-05-22
AU673175B2 (en) 1996-10-31
ATE151639T1 (de) 1997-05-15
NZ253130A (en) 1996-05-28
EP0651647A1 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
ITMI921551A1 (it) Glutatione come agente chemioprotettivo
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9406779A (pt) Complexos de inclusão de multicomponentes altamente solúveis contendo uma droga de tipo básico um ácido e uma ciclodextrina
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
ES2113652T3 (es) Pamoato de risperidona.
HUP0103922A2 (hu) Pramipexolt és egy további antidepresszánst tartalmazó depresszióellenes hatású szer
NO178965C (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
BR0112770A (pt) Agentes herbicidas
ES2133412T3 (es) 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.
ATE179164T1 (de) Hiv-proteaseinhibitoren
MX9401406A (es) Agentes receptores de adenosina selectivos para intensificar el conocimiento.
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
PT862433E (pt) Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval
SE9704770D0 (sv) New use
ATE176402T1 (de) Serinprotease enthaltender impfstoff
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
NO975790L (no) Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer
EP0645963A4 (it)
NO952308L (no) Anvendelse av ruluzoler som radiorestaurator
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970628